CCR4 ligands CCL22 and CCL17, each involved in Treg recruitment into the tumour microenvironment (TME) [29], were comparatively decreased in mice treated with sitagliptin (Figure 3F) and were consistent with the observed decrease in Treg abundance (Figure 3D). Here, CCR4 is linked to neoplasm.